A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma

Hun J. Lee, Jacob L. Schmelz, Fred Cramer, Jorge E. Romaguera, Maria Badillo, Michael Wang

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)e94-e98
JournalBritish Journal of Haematology
Volume188
Issue number6
DOIs
StatePublished - Mar 1 2020

Keywords

  • carfilzomib
  • ibrutinib
  • mantle cell lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this